Duragesic-100 and Arava drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Duragesic-100 (fentanyl) and Arava (leflunomide). Common drug interactions include nasopharyngitis among females and bone marrow failure among males.

The phase IV clinical study analyzes what interactions people have when they take Duragesic-100 and Arava. It is created by eHealthMe based on reports of 75 people who take the same drugs from the FDA, and is updated regularly.

What is Duragesic-100?

Duragesic-100 has active ingredients of fentanyl. It is often used in pain. eHealthMe is studying from 19,509 Duragesic-100 users. Check the latest studies of Duragesic-100.

What is Arava?

Arava has active ingredients of leflunomide. It is often used in rheumatoid arthritis. eHealthMe is studying from 76,040 Arava users. Check the latest studies of Arava.



On Jul, 09, 2026

75 people who take Duragesic-100 and Arava together, and have interactions are studied.

Duragesic-100 and Arava drug interactions.

What are the common drug interactions of Duragesic-100 and Arava, by gender? *:

female:

  1. Nasopharyngitis (inflammation of the nasopharynx)
  2. Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
  3. Onychoclasis (breaking of the nails)
  4. Oral candidiasis (fungal infection of mouth)
  5. Parotid gland enlargement
  6. Renal disorder (kidney disease)
  7. Respiratory failure (inadequate gas exchange by the respiratory system)
  8. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
  9. Sialoadenitis (inflammation of a salivary gland)
  10. Spinal column stenosis (narrowing of spinal column)

male:

  1. Bone marrow failure
  2. Lymphoma (cancer that begins in immune system cells)
  3. Memory impairment
  4. Nausea (feeling of having an urge to vomit)
  5. Osteonecrosis of jaw (death of bone of jaw)
  6. Sedation
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Skin cancer
  9. Skin ulcer
  10. Suicidal ideation

What are the common drug interactions of Duragesic-100 and Arava, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug toxicity
  2. Accidental death
  3. Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
  4. Pulmonary congestion (congestion in the lungs)
  5. Pulmonary oedema (fluid accumulation in the lungs)
  6. Breakthrough pain
  7. Contusion (a type of hematoma of tissue in which capillaries)
  8. Drug effect decreased
  9. Excoriation (to tear or wear off the skin of)
  10. Exostosis (formation of new bone on the surface of a bone)

40-49:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Hypertension (high blood pressure)
  3. Hypoxia (low oxygen in tissues)

50-59:

  1. Cutaneous lupus erythematosus (own immune system attacks various cells causing a wide variety of signs and symptoms)
  2. Erythema annulare (redness of the skin with sign of inflammation or infection)
  3. Rash macular (small, flat red spots)
  4. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  5. Tooth fracture

60+:

  1. Arthritis bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection)
  2. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  3. Aortic valve disease
  4. Arthralgia (joint pain)
  5. Cardiac failure
  6. Chest pain
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Pneumonia
  9. Skin ulcer
  10. Abscess jaw (tooth abscess or root abscess)

What are the existing conditions these people have? *

  1. Depression: 13 people, 17.33%
  2. Osteoporosis (bones weak and more likely to break): 12 people, 16.00%
  3. Breakthrough Pain: 12 people, 16.00%
  4. High Blood Pressure: 8 people, 10.67%
  5. Infection: 6 people, 8.00%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 8.00%
  7. Gastric Ulcer (stomach ulcer): 6 people, 8.00%
  8. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 6 people, 8.00%
  9. Constipation: 6 people, 8.00%
  10. Diabetes: 5 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Duragesic-100 and Arava?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Duragesic-100 and Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Duragesic-100:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Arava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Duragesic-100 and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Arava and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fentanyl and leflunomide (the active ingredients of Duragesic-100 and Arava, respectively), and Duragesic-100 and Arava (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: